Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet - 2Manageable Living: Eco-Accommodating Decisions for Regular day to day existence
- 3The Most Famous Virtual Entertainment Powerhouses of the Year
- 4‘Grit’ and relentless perseverance can take a toll on brain health − particularly for people facing social stresses like racism
- 5New Cheetos and Doritos will be free of artificial dyes
- Paraplegic engineer becomes the first wheelchair user to blast into space
- Israel faces tough choices over haredi draft exemptions, legal expert warns
- Abbott issues US device correction for some glucose monitors over faulty readings risk
- Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
- Magnetic fossils may reveal ancient creature's internal 'GPS system'
- German politician urges more face-to-face interaction in digital age
- Remote Work Survival manual: Helping Efficiency at Home
- Figure out How to Protect Your Gold Venture from Unpredictability
- Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique
